Mario Ostrowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Made-in-Canada coronavirus vaccine starts human clinical trials CBC/Radio-Canada © Providence Therapeutics/The Canadian Press A healthy volunteer receives an injection in this undated image provided by Providence Therapeutics. Human clinical trials have begun in Toronto for the company's proposed COVID-19 vaccine. A made-in-Canada vaccine to protect against COVID-19 began human clinical trials Tuesday in Toronto, says the biotechnology company that developed the vaccine. Toronto-based Providence Therapeutics said three shots will be given to 60 adult volunteers at a clini...

Share this article mRNA vaccine is first fully made-in-Canada vaccine to undergo trials TORONTO and CALGARY, AB, Dec. 23, 2020 /CNW/ - Providence Therapeutics today announced that Health Canada has provided a Notice of Authorization for its Clinical Trial Application. This permits the Canadian biotech company to begin human clinical trials of its COVID-19 vaccine. PTX-COVID19-B is a messenger RNA (mRNA) vaccine and is the first fully made-in-Canada COVID vaccine to reach this stage of development. Health Canada's authorization means Phase I clinical trials will begin early in the New Year...

Tania Watts (L) and Mario Ostrowski (Handout) New findings from Temerty Faculty of Medicine researchers may help explain why SARS-CoV-2 – the virus that causes COVID-19 – can cause more severe inflammation and lung tissue damage than a regular, seasonal influenza virus. “The research helps us understand the immune response by people to the virus that causes COVID-19,” said physician Tania Watts, co-lead on the study and professor in the department of immunology. “We have gained insights into why some people might get severe outcomes from infection from SARS-CoV-2.” Published...

Research teams in Montreal, Toronto looking at how COVID-19 impacts immunity Last Updated Dec 17, 2020 at 1:23 pm MDT FILE -- Specimens to be tested for COVID-19 are seen at a lab, in Surrey, B.C., on Thursday, March 26, 2020. THE CANADIAN PRESS/Darryl Dyck MONTREAL – Research from two university teams is shedding a little bit of light on why COVID-19 patients have more severe side effects than those with the regular seasonal flu. The teams, from the Université de Montréal and the University of Toronto are backed by Canada’s COVID-19 Immunity Task Force (CITF). The Toronto team recently...